Identification
Name Kanamycin
Accession Number DB01172 (APRD00026)
Type small molecule
Description Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. [PubChem]
Structure
Categories (*)
Molecular Weight 484.4986
Groups approved
Monoisotopic Weight 484.238058014
Pharmacology
Indication For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.
Mechanism of action Aminoglycosides like kanamycin "irreversibly" bind to specific 30S-subunit proteins and 16S rRNA. Specifically Kanamycin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes.
Absorption Kanamycin is rapidly absorbed after intramuscular injection and peak serum levels are generally reached within approximately one hour. Poor oral and topical absorption except with severe skin damage.
Protein binding Not Available
Biotransformation Not Available
Route of elimination Not Available
Toxicity Mild and reversible nephrotoxicity may be observed in 5 - 25% of patients. Amikacin accumulates in proximal renal tubular cells. Tubular cell regeneration occurs despite continued drug exposure. Toxicity usually occurs several days following initiation of therapy. May cause irreversible ototoxicity. Otoxocity appears to be correlated to cumulative lifetime exposure. Drug accumulation in the endolymph and perilymph of the inner ear causes irreversible damage to hair cells of the cochlea or summit of ampullar cristae in the vestibular complex. High frequency hearing is lost first with progression leading to loss of low frequency hearing. Further toxicity may lead to retrograde degeneration of the 8th cranial (vestibulocochlear) nerve. Vestibular toxicity may cause vertigo, nausea, vomiting, dizziness and loss of balance. Oral LD50 is 17500 mg/kg in mice, over 4 g/kg in rats, and over 3 g/kg in rabbits.
Affected organisms
  • Enteric bacteria and other eubacteria
Interactions
Drug Interactions
Drug Mechanism of interaction
Bumetanide Increased ototoxicity
Cefotaxime Increased risk of nephrotoxicity
Cefotetan Increased risk of nephrotoxicity
Cefoxitin Increased risk of nephrotoxicity
Ceftazidime Increased risk of nephrotoxicity
Ceftriaxone Increased risk of nephrotoxicity
Colistimethate Aminoglycosides may enhance the nephrotoxic effect of Colistimethate. Aminoglycosides may enhance the neuromuscular-blocking effect of Colistimethate. Due to the potential for additive or synergistic toxicities (including both nephrotoxicity and neuromuscular blockade) between colistimethate and the aminoglycoside antibiotics, this combination should be avoided whenever possible. If these agents must be used together, patients' renal and neuromuscular function should be monitored closely.
Ethacrynic acid Increased ototoxicity
Furosemide Increased ototoxicity
Ticarcillin Ticarcillin may reduce the serum concentration of Kanamycin. Ticarcillin may inactivate Kanamycin in vitro and the two agents should not be administered simultaneously through the same IV line.
Food Interactions Not Available
30S ribosomal protein S12
Name 30S ribosomal protein S12
Gene Name rpsL
Pharmacological action yes
Actions inhibitor
References
  • Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. - Pubmed
  • Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. - Pubmed
  • Stavropoulos TA, Strathdee CA: Synergy between tetA and rpsL provides high-stringency positive and negative selection in bacterial artificial chromosome vectors. Genomics. 2001 Feb 15;72(1):99-104. - Pubmed
  • Gondo Y, Shioyama Y, Nakao K, Katsuki M: A novel positive detection system of in vivo mutations in rpsL (strA) transgenic mice. Mutat Res. 1996 May 17;360(1):1-14. - Pubmed
  • Amanuma K, Takeda H, Amanuma H, Aoki Y: Transgenic zebrafish for detecting mutations caused by compounds in aquatic environments. Nat Biotechnol. 2000 Jan;18(1):62-5. - Pubmed
DTHybrid score 1.6977
16S rRNA
Name 16S rRNA
Gene Name Not Available
Pharmacological action yes
Actions inhibitor
References
  • Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. - Pubmed
  • Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. - Pubmed
  • Roy U, Nair D: Biodiversity of organotin resistant Pseudomonas from west coast of India. Ecotoxicology. 2007 Mar;16(2):253-61. Epub 2006 Nov 28. - Pubmed
  • Pikuta EV, Hoover RB, Bej AK, Marsic D, Whitman WB, Krader PE, Tang J: Trichococcus patagoniensis sp. nov., a facultative anaerobe that grows at -5 degrees C, isolated from penguin guano in Chilean Patagonia. Int J Syst Evol Microbiol. 2006 Sep;56(Pt 9):2055-62. - Pubmed
  • Chung JH, Park YS, Kim J, Shin GW, Nam MH, Oh MK, Kim CW, Jung GY, Hyun Park J: Parallel analysis of antimicrobial activities in microbial community by SSCP based on CE. Electrophoresis. 2007 Jul;28(14):2416-23. - Pubmed
DTHybrid score Not Available
Aminoglycoside 2'-N-acetyltransferase
Name Aminoglycoside 2'-N-acetyltransferase
Gene Name aac
Actions Not Available
References
  • -
  • Vetting MW, Hegde SS, Javid-Majd F, Blanchard JS, Roderick SL: Aminoglycoside 2'-N-acetyltransferase from Mycobacterium tuberculosis in complex with coenzyme A and aminoglycoside substrates. Nat Struct Biol. 2002 Sep;9(9):653-8. - Pubmed
DTHybrid score Not Available
Kanamycin nucleotidyltransferase
Name Kanamycin nucleotidyltransferase
Gene Name knt
Actions Not Available
References
  • -
  • Gates CA, Northrop DB: Substrate specificities and structure-activity relationships for the nucleotidylation of antibiotics catalyzed by aminoglycoside nucleotidyltransferase 2''-I. Biochemistry. 1988 May 17;27(10):3820-5. - Pubmed
DTHybrid score 1.0646
Aminoglycoside 3'-phosphotransferase
Name Aminoglycoside 3'-phosphotransferase
Gene Name aphA1
Actions Not Available
References
  • -
  • Wieninger SA, Serpersu EH, Ullmann GM: ATP binding enables broad antibiotic selectivity of aminoglycoside phosphotransferase(3')-IIIa: an elastic network analysis. J Mol Biol. 2011 Jun 10;409(3):450-65. doi: 10.1016/j.jmb.2011.03.061. Epub 2011 Apr 6. - Pubmed
DTHybrid score Not Available
Id Partner name Gene Name Score
6704 30S ribosomal protein S12 rpsL 1.6977
3390 Aminoglycoside 3'-phosphotransferase aphA 1.0648
4240 Protein disulfide-isomerase P4HB 0.1513
4565 Aminoglycoside 6'-N-acetyltransferase aac(6')-Iy 0.1355
5682 Ribonuclease pancreatic RNASE1 0.1013
1162 C-X-C chemokine receptor type 4 CXCR4 0.0691
1244 Low-density lipoprotein receptor-related protein 2 LRP2 0.0525
1729 Solute carrier family 22 member 6 SLC22A6 0.044
6208 30S ribosomal protein S13 rpsM 0.0281
6706 30S ribosomal protein S13 rpsM 0.0281
6209 30S ribosomal protein S19 rpsS 0.0245
6712 30S ribosomal protein S19 rpsS 0.0245
6726 30S ribosomal protein S19 rpsS 0.0245
6207 30S ribosomal protein S14 rpsN 0.0245
140 30S ribosomal protein S9 rpsI 0.0185
6719 30S ribosomal protein S9 rpsI 0.0185
6725 30S ribosomal protein S9 rpsI 0.0185
4576 Aac(6')-Ii protein aac(6')-Ii 0.0098
4579 Serine acetyltransferase cysE 0.0098
6807 Serine acetyltransferase cysE 0.0098
4567 Putative acyl-CoA thioester hydrolase HI0827 HI_0827 0.0098
4564 YvbK protein yvbK 0.0098
4566 Acyl-CoA hydrolase BC_2038 0.0098
4572 Acyl-CoA hydrolase BH0798 0.0098
4037 Hypothetical protein GPX1 0.0098
4297 Hypothetical protein SP_1951 0.0098
4521 Hypothetical protein BC_2969 0.0098
4540 Hypothetical protein TM_1070 0.0098
4555 Hypothetical protein MT1739 0.0098
4569 Hypothetical protein mshD 0.0098
4578 Hypothetical protein PA3270 0.0098
4747 Hypothetical protein PA3967 0.0098
5177 Hypothetical protein TM_0096 0.0098
5194 Hypothetical protein PA1204 0.0098
5240 Hypothetical protein Rv2991 0.0098
5370 Hypothetical protein TM_1158 0.0098
5710 Hypothetical protein Tb927.5.1360 0.0098
4577 4'-phosphopantetheinyl transferase sfp sfp 0.0098
2528 Fatty acid metabolism regulator protein fadR 0.0098
6740 Fatty acid metabolism regulator protein fadR 0.0098
3489 Acetyl-coenzyme A synthetase acs 0.0085
3560 Gentamicin 3'-acetyltransferase aacC1 0.0085
2396 Formyl-coenzyme A transferase frc 0.0085
3457 Formyl-coenzyme A transferase frc 0.0085
4574 PROBABLE NAPHTHOATE SYNTHASE MENB menB 0.0085
3024 Crotonobetainyl-CoA:carnitine CoA-transferase caiB 0.0085
3317 Holo-[acyl-carrier-protein] synthase acpS 0.0084
4381 Holo-[acyl-carrier-protein] synthase acpS 0.0084
3125 Protease synthase and sporulation negative regulatory protein PAI 1 paiA 0.0084
4563 Acetyl transferase rimL 0.0084
3729 Citrate synthase gltA 0.0084
4575 Citrate synthase cit 0.0084
4580 Citrate synthase gltA 0.0084
2409 Acetyl-CoA acetyltransferase, cytosolic ACAT2 0.0084
2560 Galactoside O-acetyltransferase lacA 0.008
3697 Bifunctional protein glmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase glmU 0.0078
3178 Formate acetyltransferase 1 pflB 0.0078
3199 Phosphopantetheine adenylyltransferase coaD 0.0078
3543 Phosphopantetheine adenylyltransferase coaD 0.0078
3567 Phosphopantetheine adenylyltransferase coaD 0.0078
5289 Phosphopantetheine adenylyltransferase coaD 0.0078
2377 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex Not Available 0.0078
2285 Streptogramin A acetyltransferase vatD 0.0078
4573 Histone acetyltransferase PCAF KAT2B 0.0078
2248 Malate synthase G glcB 0.0077
3190 Malate synthase G glcB 0.0077
2371 Pantothenate kinase coaA 0.0077
4404 FcbC1 protein fcbC 0.0074
2376 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase dapD 0.007
551 Carnitine O-acetyltransferase CRAT 0.007
615 3-oxoacyl-[acyl-carrier-protein] synthase 3 fabH 0.0064
3138 3-oxoacyl-[acyl-carrier-protein] synthase 3 fabH 0.0064
4568 3-oxoacyl-[acyl-carrier-protein] synthase 3 fabH 0.0064
6370 3-oxoacyl-[acyl-carrier-protein] synthase 3 fabH 0.0064
2596 Acetyl-CoA acetyltransferase phbA 0.0064
631 3-hydroxy-3-methylglutaryl-coenzyme A reductase HMGCR 0.0049
3387 3-hydroxy-3-methylglutaryl-coenzyme A reductase mvaA 0.0049